The treatment of Cataracts & Periodontitis with vitamins

Cataracts and Periodontitis: Mitamins custom make quality formulas for the treatment of Cataracts & Periodontitis with vitamins. A Cataracts & Periodontitis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Periodontitis

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    400
    mg
    667%
    Vitamin E
    200
    IU
    667%
    Riboflavin
    75
    mg
    4412%
    Folate
    400
    mcg
    100%
    Zinc
    10
    mg
    67%
    Selenium
    200
    mcg
    286%
    Alpha Lipoic Acid
    50
    mg
    *
  • Amount Per Serving
    % DV
    CoQ-10
    40
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    Green Tea Extract
    100
    mg
    *
    Quercetin
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Cataracts and Periodontitis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Supporting Health Professionals In The Northern Territory, Australia
The Commonwealth Government has committed a further $100 million for more doctors, nurses, allied health professionals and specialist services as part of the Northern Territory Emergency Response.A new Remote Area Health Corps will be established to attract and support the increased numbers of urban-based health professionals needed to provide more health care in remote communities.
Immtech Announces Interim Analysis In Phase III African Sleeping Sickness Trial
Immtech Pharmaceuticals, Inc. (Amex: IMM) announced the completion of interim analysis of itsPhase III pivotal clinical trial of Immtech's oral drug candidate, pafuramidine. An independent Data Safety Monitoring Board (DSMB) conducted the interim analysis and recommended that the trial should continue as planned.
This information concerning the support of Cataracts and Periodontitis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments